Literature DB >> 19243990

Natural human infections with Vaccinia virus during bovine vaccinia outbreaks.

André Tavares Silva-Fernandes1, Carlos Eurico Pires Ferreira Travassos, Jaqueline Maria Siqueira Ferreira, Jônatas Santos Abrahão, Eliseu Soares de Oliveira Rocha, Flávia Viana-Ferreira, João Rodrigues dos Santos, Cláudio Antônio Bonjardim, Paulo César Peregrino Ferreira, Erna Geessien Kroon.   

Abstract

BACKGROUND: Bovine vaccinia is an exanthematic disease caused by Vaccinia virus (VACV). This zoonosis has been associated with several cases of bovine infection, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by fever, headache, malaise, myalgia and axillary, inguinal and cervical lymphadenopathy. VACV infections have a significant public health impact due to their occupational character, high frequency of transmission and the improper medical treatment often applied.
OBJECTIVES: To study natural human infection by VACV and to analyze clinical and epidemiological aspects, emphasizing the patients' immunological status. STUDY
DESIGN: Ninety-eight individuals from rural properties with bovine vaccinia (BV) outbreaks who were at risk due to contact were submitted to epidemiological and clinical studies. From these individuals, 54 sera were analyzed by serological and molecular procedures. This study was conducted in Rio de Janeiro State from September 2002 to October 2006.
RESULTS: The clinical frequency of infection was 52.0%, with 57.4% ELISA and 43.0% PRNT-positive reactions. DNAemia was detected in 18.5% of the analyzed sera, and 50% of smallpox-vaccinated individuals developed symptoms.
CONCLUSIONS: This study confirms the high clinical frequency of human VACV infection, even among vaccinated individuals. The infection was related to detection of IgG- or IgM-specific antibodies that correlates in most of the cases with positive PRNT. The DNAemia suggests viremia during VACV natural infections. Our data indicate that patients vaccinated against smallpox may no longer be protected.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243990     DOI: 10.1016/j.jcv.2009.01.007

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  30 in total

1.  Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.

Authors:  Adam R Hersperger; Nicholas A Siciliano; Laurence C Eisenlohr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

3.  The poxvirus A35 protein is an immunoregulator.

Authors:  Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Intrafamilial transmission of Vaccinia virus during a bovine Vaccinia outbreak in Brazil: a new insight in viral transmission chain.

Authors:  Graziele Pereira Oliveira; André Tavares Silva Fernandes; Felipe Lopes de Assis; Pedro Augusto Alves; Ana Paula Moreira Franco Luiz; Leandra Barcelos Figueiredo; Cláudia Maria Costa de Almeida; Carlos Eurico Pires Ferreira Travassos; Giliane de Souza Trindade; Jônatas Santos Abrahão; Erna Geessien Kroon
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

5.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

6.  Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Authors:  Kristina E Rehm; Rachel L Roper
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

7.  Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil.

Authors:  Galileu Barbosa Costa; Jaqueline Silva de Oliveira; Michael B Townsend; William C Carson; Iara Apolinário Borges; Andrea M McCollum; Erna Geessien Kroon; Panayampalli Subbian Satheshkumar; Mary G Reynolds; Yoshinori J Nakazawa; Giliane de Souza Trindade
Journal:  Pathogens       Date:  2021-04-23

8.  Orthopoxvirus genes that mediate disease virulence and host tropism.

Authors:  Sergei N Shchelkunov
Journal:  Adv Virol       Date:  2012-07-30

9.  Serologic evidence of orthopoxvirus infection in buffaloes, Brazil.

Authors:  Felipe Lopes de Assis; Graziele Pereira; Cairo Oliveira; Gisele Olinto Libânio Rodrigues; Marcela Menezas Gomes Cotta; Andre Tavares Silva-Fernandes; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

10.  One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil?

Authors:  Jônatas S Abrahão; Maria Isabel M Guedes; Giliane S Trindade; Flávio G Fonseca; Rafael K Campos; Bruno F Mota; Zélia I P Lobato; André T Silva-Fernandes; Gisele O L Rodrigues; Larissa S Lima; Paulo C P Ferreira; Cláudio A Bonjardim; Erna G Kroon
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.